Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Taylor

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Transplantation|August 12, 2015
Logistical Factors Influencing Cold Ischemia Times in Deceased Donor Kidney TransplantsSussie Shrestha, Lisa Bradbury, Matthew Boal, et al.
Kidney International|April 11, 2014
Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantationVasilios Kosmoliaptsis, Olivera Gjorgjimajkoska, Linda D Sharples, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2011
HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor bindingDes C Jones, Vasilis Kosmoliaptsis, Richard Apps, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 14, 2010
Association of the human leucocyte antigen region with susceptibility to Parkinson's diseaseMisuzu Saiki, Amie Baker, Caroline H Williams-Gray, et al.
Hepatology (Baltimore, Md.)|March 18, 2011
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitisJohannes R Hov, Vasilis Kosmoliaptsis, James A Traherne, et al.
Transplantation|January 26, 2010
Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantationCraig J Taylor, Vasilis Kosmoliaptsis, Linda D Sharples, et al.
Transplantation|February 18, 2004
Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantationAnna L Taylor, Paul Gibbs, Surendran Sudhindran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.
Plos Genetics|March 8, 2014
LILRB2 interaction with HLA class I correlates with control of HIV-1 infectionArman A Bashirova, Enrique Martin-Gayo, Des C Jones, et al.
Transplantation|December 15, 2012
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantationBrian D Tait, Caner Süsal, Howard M Gebel, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Transplantation|August 12, 2015
Logistical Factors Influencing Cold Ischemia Times in Deceased Donor Kidney TransplantsSussie Shrestha, Lisa Bradbury, Matthew Boal, et al.
Kidney International|April 11, 2014
Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantationVasilios Kosmoliaptsis, Olivera Gjorgjimajkoska, Linda D Sharples, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2011
HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor bindingDes C Jones, Vasilis Kosmoliaptsis, Richard Apps, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 14, 2010
Association of the human leucocyte antigen region with susceptibility to Parkinson's diseaseMisuzu Saiki, Amie Baker, Caroline H Williams-Gray, et al.
Hepatology (Baltimore, Md.)|March 18, 2011
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitisJohannes R Hov, Vasilis Kosmoliaptsis, James A Traherne, et al.
Transplantation|January 26, 2010
Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantationCraig J Taylor, Vasilis Kosmoliaptsis, Linda D Sharples, et al.
Transplantation|February 18, 2004
Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantationAnna L Taylor, Paul Gibbs, Surendran Sudhindran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five yearsChristopher J E Watson, J Andrew Bradley, Peter J Friend, et al.
Plos Genetics|March 8, 2014
LILRB2 interaction with HLA class I correlates with control of HIV-1 infectionArman A Bashirova, Enrique Martin-Gayo, Des C Jones, et al.
Transplantation|December 15, 2012
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantationBrian D Tait, Caner Süsal, Howard M Gebel, et al.
Pageof 6